CompoAtlas

Bio-D3

Natural health product licensed in Canada

Licence holder
Biomed Pharma
NPN or DIN-HM
80142888
Status
Active licence
Licence date
23 July 2025
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

50 microgram50 µg

Non-medicinal ingredients

Poly(éthylène glycol), Cellulose microcristalline, Laque d'aluminium bleu FD&C n° 1, Talc, Phosphate de calcium, dibasique, anhydre, D&C Jaune n° 10, Poly(alcool vinylique), Stéarate de magnésium, Dioxyde de silicium colloïdal, Croscarmellose de sodium, Dioxyde de titane

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Comprimé1 Tous les jours

Uses authorised in Canada

Aide à prévenir une carence en vitamine D.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80142888

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line